Restor3d
Overview
Restor3d is an innovative medical technology company that focuses on designing and manufacturing 3D-printed, personalized orthopedic implants. Founded in 2017 by Ken Gall, and co-founded by Andrew Miller, the company is headquartered in Durham, North Carolina. With significant advancements in additive manufacturing and biomaterials, restor3d aims to enhance patient care through personalized surgical solutions. The company has raised over $114 million in funding to date.
Recent Developments
- September 2024: Restor3d launched the Kinos Range articulating surface, a 3D-printed implant designed to enhance ankle arthroplasty. This product offers surgeons the flexibility to customize articulations based on patient-specific needs, providing improved stability and biomechanics during surgery.
- August 2024: The company expanded into robotics and navigation by appointing industry leaders to new senior positions. This strategic move supports their mission to improve patient outcomes through cutting-edge technology and personalized care solutions.
- June 2024: Restor3d successfully closed a $70 million financing round, comprising $55 million in Series A funding and $15 million in debt financing. The funds aim to advance the development of their 3D-printed implant systems, invest in advanced 3D printing technologies, and expand educational initiatives for surgeons.
- January 2024: Restor3d completed a key initiative post its acquisition of Conformis, enhancing its portfolio with cost-effective and clinically differentiated solutions in personalized orthopedic devices.
- April 2023: Gained FDA clearance for its Axiom patient-specific resection system, marking significant progress in personalized solutions for ankle arthroplasty.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2017 |
| Headquarters | Durham, North Carolina, USA |
| Founders | Ken Gall, Andrew Miller |
| Revenue | Not publicly disclosed |
| Profits | Not publicly disclosed |
| Key Investors | Trinity Capital, Summers Value Partners |
| Industry | Medical Devices |
| Number of Employees | 201-500 |
Early History
Restor3d was founded in 2017 as an innovative startup focusing on personalized orthopedic implants using 3D printing technology. The company emerged from a laboratory at Duke University, under the guidance of its founders Ken Gall and Andrew Miller. Initially operating as Additive Device, it quickly distinguished itself by leveraging advanced biomaterials and additive manufacturing techniques. In its initial years, Restor3d concentrated on developing customized implant solutions aimed at improving the fit and functionality of orthopedic devices, catering to the specific anatomical needs of patients.
Company Profile and Achievements
Restor3d specializes in developing and manufacturing 3D-printed orthopedic implants, offering patient-specific solutions that range from total ankle replacements to complex spine and trauma reconstructions. Their proprietary technology integrates advanced 3D printing methods, AI-based planning, and design automation tools. Significant milestones include:
- Acquisition of Kinos Medical in 2021, expanding its total ankle replacement market.
- Merger with Conformis in 2023, broadening its personalized implant portfolio into hip and knee solutions.
- Multiple FDA clearances for their innovative implant systems.
- Establishment of an in-house 'powder to sterile product' rapid production environment. The company's commitment to personalized, high-quality medical care is evident in its continuous pursuit of technological advancements.
Current Operations and Market Position
Restor3d is recognized as a leader in the medical device industry, particularly in personalized musculoskeletal implants. The company operates primarily within the United States but has intentions for broader market penetration. By integrating robotics, navigation, and advanced AI planning into its portfolio, restor3d continues to sharpen its competitive edge and expand its market reach. The company’s emphasis on patient-specific solutions underscores significant market differentiation, aiming to enhance surgical outcomes and expand personalized healthcare solutions globally.
Conclusion
Restor3d stands at the forefront of medical technology innovation in orthopedics through its dedication to personalized healthcare using additive manufacturing and AI technologies. With substantial funding and strategic leadership, the company has positioned itself for significant growth and impact within the orthopedic device industry. As the company continues to expand its capabilities in robotics and navigation, it is set to further revolutionize patient care with patient-specific solutions, potentially setting new industry standards.